A case of Vibrio vulnificus keratitis.
You
In-Cheon
IC
Department of Ophthalmology, Chonnam National University Medical School, Gwang-Ju, South Korea.
Ahn
Min
M
Department of Ophthalmology, Chonbuk National University, College of Medicine, Jeon-Ju, South Korea.
Yoon
Kyoung-Won
KW
Department of Internal Medicine, Chonnam National University Medical School, Gwang-Ju, South Korea.
Yoon
Kyung-Chul
KC
Department of Ophthalmology, Chonnam National University Medical School, Gwang-Ju, South Korea. kcyoon@chonnam.ac.kr.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002442:Ceftazidime / Q000627:therapeutic use; D003320:Corneal Ulcer / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D004318:Doxycycline / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D015818:Eye Infections, Bacterial / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D005131:Eye Injuries / Q000382:microbiology; D005260:Female; D024841:Fluoroquinolones / Q000627:therapeutic use; D000077734:Gatifloxacin; D006801:Humans; D008875:Middle Aged; D014031:Tobramycin / Q000627:therapeutic use; D014735:Vibrio Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D041261:Vibrio vulnificus / Q000302:isolation & purification*
D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones; D002442:Ceftazidime; D000077734:Gatifloxacin; D004318:Doxycycline; D014031:Tobramycin